Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1427-1436

  Shornick, Laurie P ^a   De Togni, Pietro ^a,c   Mariathasan, Sanjeev ^a   Goellner, Joseph ^b   Strauss Schoenberger, Jena ^b   Karr, Robert W ^b   Ferguson, Thomas A ^a   Chaplin, David D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE DERIVATIVE; GALACTOSAMINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTACT ALLERGY; CONTACT SENSITIZATION; CONTROLLED STUDY; GENE TARGETING; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SEPTIC SHOCK;

ANIMALS; BASE SEQUENCE; DERMATITIS, CONTACT; EPIDERMIS; GENE TARGETING; INTERLEUKIN-1; MACROPHAGES, PERITONEAL; MICE; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; PICRYL CHLORIDE; RECOMBINANT PROTEINS; SHOCK, SEPTIC;

EID: 0029916522     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1427     Document Type: Article

References (50)

1. Silver, A.R.J., W.K. Masson, A.M. George, J. Adam, and R. Cox. 1990. The IL-1α and β genes are closely linked (less than 70 kb) on chromosome 2. Somatic Cell Mol. Genet. 16:549-556.
2. D'Eustachio, P., S. Jadidi, R.C. Fuhlbrigge, P.W. Gray, and D.D. Chaplin. 1987. Interleukin-1 α and β genes: linkage on chromosome 2 in the mouse. Immunogenetics. 26:339-343.
3. March, C.J., B. Mosley, A. Larsen, D.P. Cerretti, G. Braedt, V. Price, S. Gillis, C.S. Henney, S.R. Kronheim, K. Grabstein et al. 1985. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature (Lond.). 315:641-647.
4. Dinarello, C.A. 1994. Interleukin-1. Adv. Pharmacol. 25:21-51.
5. Kobayashi, Y., K. Yamamoto, T. Saido, H. Kawasaki, J.J. Oppenheim, and K. Matsushima. 1990. Identification of calcium-activated neutral protease as a processing enzyme of human interleukin-1α. Proc. Natl. Acad. Sci. USA. 87:5548-5552.
6. Kostura, M.J., M.J. Tocci, G. Limjuco, J. Chin, P. Cameron, A.G. Hillman, N.A. Chartrain, and J.A. Schmidt. 1989. Identification of a monocyte specific pre-interleukin-1β convertase activity. Proc. Natl. Acad. Sci. USA. 86:5227-5231.
7. Chizzonite, R., T. Truitt, P.L. Kilian, A.S. Stern, P. Nunes, K.P. Parker, K.L. Kaffka, A.O. Chua, D.K. Lugg, and U. Gubler. 1989. Two high-affinity interleukin 1 receptors represent separate gene products. Proc. Natl. Acad. Sci. USA. 86: 8029-8033.
8. Sims, J.E., C.J. March, D. Cosman, M.B. Widmer, H.R. MacDonald, C.J. McMahan, C.E. Grubin, J.M. Wignall, J.L. Jackson, S.M. Call et al. 1988. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science (Wash. DC). 241:585-589.
9. Sims, J.E., R.B. Acres, C.E. Grubin, C.J. McMahan, J.M. Wignall, C.J. March, and S.K. Dower. 1989. Cloning the interleukin-1 receptor from human T cells. Proc. Natl. Acad. Sci. USA. 86:8946-8950.
10. Dower, S.K., S.R. Kronheim, T.P. Hopp, M. Cantrell, M. Deeley, S. Gillis, C.S. Henney, and D.L. Urdal. 1986. The cell surface receptors for interleukin-1α and interleukin-1β are identical. Nature (Lond.). 324:266-268.
11. Beutler, B. 1992. Tumor Necrosis Factors: the Molecules and Their Emerging Role in Medicine. Raven Press, Ltd., NY. 590 pp.
12. Akira, S., T. Hirano, T. Taga, and T. Kishimoto. 1990. Biology of the multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J. 4:2860-2867.
13. Dinarello, C.A. 1989. Interleukin-1 and its biologically related cytokines. Adv. Immunol. 44:153-205.
14. Fuhlbrigge, R.C., K.C.F. Sheehan, R.D. Schreiber, D.D. Chaplin, and E.R. Unanue. 1988. Monoclonal antibodies to murine IL-1α. Production, characterization, and inhibition of membrane-associated IL-1 activity. J. Immunol. 141:2643-2650.
15. Hogquist, K.A., M.A. Nett, K.C.F. Sheehan, K.D. Pendleton, R.D. Schreiber, and D.D. Chaplin. 1991. Generation of monoclonal antibodies to murine IL-1β and demonstration of IL-1 in vivo. J. Immunol. 146:1534-1540.
16. Rogers, H.W., K.C.F. Sheehan, L.M. Brunt, S.K. Dower, E.R. Unanue, and R.D. Schreiber. 1992. Interleukin-1 participates in the development of anti-Listeria responses in normal and SCID mice. Proc. Natl. Acad. Sci. USA. 89:1011-1015.
17. Burger, D., R. Chicheportiche, J.G. Giri, and J.M. Dayer. 1995. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J. Clin. Invest. 96:38-41.
18. Eisenberg, S.P., R.J. Evans, W.P. Arend, E. Verderber, M.T. Brewer, C.H. Hannum, and R.C. Thompson. 1990. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature (Loud.). 343:341-346.
19. Long, N.C., I. Otterness, S.L. Kunkel, V.A.J., and M.J. Kluger. 1990. Roles of mterleukin 1β and tumor necrosis factor in lipopolysaccharide fever in rats. Am. J. Physiol. 259: R724-R728.
20. McIntyre, K.W., G.J. Stepan, W.R. Benjamin, J.M. Plocinski, K.L. Kaffka, C.A. Campden, R.A. Chizzonite, and P.L. Kilian. 1991. Inhibition of interleukin-1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J. Exp. Med. 173:931-939.
21. Rogers, H.W., C.S. Tripp, R.D. Schreiber, and E.R. Unanue. 1994. Endogenous IL-1 is required for neutrophil recruitment and macrophage activation during murine Listeriosis. J. Immunol. 153:2093-2101.
22. Geiger, T., H. Towbin, A. Cosenti-Vargas, O. Zingel, J. Arnold, C. Rordorf, M. Glatt, and K. Vosbeck. 1993. Neutralization of interleukin-1β activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response. Clin. Exp. Rheumatol. 11:515-522.
23. Van den Berg, W.B., L.A.B. Joosten, M. Helsen, and F.A.J. Van de Loo. 1994. Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin. Exp. Immunol. 95:237-243.
24. Probert, L., D. Plows, G. Kontogeorgos, and G. Kollias. 1995. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur. J. Immunol. 25:1794-1797.
25. Enk, A.H., and S.I. Katz. 1991. Early molecular events in the induction phase of contact sensitivity. Proc. Natl. Acad. Sci. USA. 89:1398-1402.
26. Enk, A.H., V.L. Angeloni, M.C. Udey, and S.I. Katz. 1993. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in the skin. J. Immunol. 150:3698-3704.
27. Enk, A.H., and S.I. Katz. 1992. Early events in the induction phase of contact sensitivity. J. Invest. Dermatol. 99:39S-41S.
28. Zheng, H., D. Fletcher, W. Kozak, M. Jiang, K.J. Hofmann, C.A. Conn, D. Soszynski, C. Grabiec, M.E. Trumbauer, A. Shaw et al. 1995. Resistance to fever induction and impaired acute-phase response in interleukin-1β-deficient mice. Immunity. 3:9-19.
29. Kunkel, T.A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA. 82:488-492.
30. Mansour, S.L., K.R. Thomas, and M.R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryoderived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature (Lond.). 336:348-352.
31. Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell. 64:693-702.
32. De Togni, P., J. Goellner, N. Ruddle, P.R. Streeter, A. Fick, S. Mariathasan, R. Carlson, L. Shornick, J. Strauss-Schoenberger, J.H. Russell, R. Karr, and D.D. Chaplin. 1994. Abnormal development of peripheral lymphoid organs in lymphotoxin deficient mice. Science (Wash. DC). 264:703-707.
33. Blin, N., and D.W. Stafford. 1976. A general method for isolation of high molecular weight DNA from eukaryotes. Nudeic Acids Res. 3:2303-2309.
34. Maniatis, T., E.F. Fritsch, and J. Sambrook. 1982. Molecular Cloning: A Laboratory Manual. 1st ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 545 pp.
35. Nett, M.A., D.P. Cerretti, D.R. Berson, J. Seavitt, D.J. Gilbert, N.A. Jenkins, N.G. Copeland, R.A. Black, and D.D. Chaplin. 1992. Molecular cloning of the murine IL-1β converting enzyme cDNA. J. Immunol. 149:3254-3259.
36. Chirgwin, J.M., A.E. Przybyla, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 18:5294-5299.
37. Lomedico, P.T., U. Gubler, C.P. Hellmann, M. Dukovich, J.G. Giri, Y.C. Pan, K. Collier, R. Semionow, A.O. Chua, and S.B. Mizel. 1984. Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature (Lond.). 312:458-462.
38. Gray, P.W., D. Glaister, E. Chen, D.V. Goeddel, and D. Pennica. 1986. Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1β. J. Immunol. 137:3644-3648.
39. Ferguson, T.A., H. Mizutani, and T.S. Kupper. 1991. Two integrin-binding peptides abrogate T cell-mediated immune responses in vivo. Proc. Natl. Acad. Sci. USA. 88:8072-8076.
40. Telford, J.L., G. Macchia, A. Massone, V. Carinci, E. Palla, and M. Melli. 1986. The murine interleukin-1β gene: structure and evolution. Nucleic Acids Res. 14:9955-9963.
41. Hogquist, K.A., M.A. Nett, E.R. Unanue, and D.D. Chaplin. 1991. Interleukin-1 is processed and released during apoptosis. Proc. Natl. Acad. Sci. USA. 88:8485-8489.
42. Li, P., H. Allen, S. Banerjee, S. Franklin, L. Herzog, C. Johnston, J. McDowell, M. Paskind, L. Rodman, J. Salfeld et al. 1995. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell. 80:401-411.
43. Kuida, K., J.A. Lippke, G. Ku, M.W. Harding, D.J. Livingston, M.S. Su, and R.A. Flavell. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science (Wash. DC). 267:2000-2003.
44. Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. Espevik. 1989. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J. Exp. Med. 169:333-338.
45. Rothe, J., W. Lesslauer, H. Lotscher, Y. Lang, P. Koebel, F. Kontgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature (Lond.) 364:798-802.
46. Car, B.D., V.M. Eng, B. Schnyder, L. Ozmen, S. Huang, P. Gallay, D. Heumann, M. Aguet, and B. Ryffel. 1994. Interferon-γ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179:1437-1444.
47. Alexander, H.R., G.M. Doherty, C.M. Buresh, D.J. Venzon, and J.A. Norton. 1991. A recombinant human receptor antagonist to interleukin-1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 173:1029-1032.
48. Ohlsson, K., P. Bjork, M. Bergenfeldt, R. Hageman, and R.C. Thompson. 1990. Interleukin-1 receptor antagonist reduces mortality from endotoxic shock. Nature (Lond.). 348: 550-552.
49. Rosenwasser, T.A., K.A. Hogquist, S.F. Nothwehr, S. Bradford-Goldberg, P.O. Olins, D.D. Chaplin, and J.I. Gordon. 1990. Compartmentalization of mammalian proteins produced in Escherichia coli. J. Biol. Chem. 265:13066-13072.
50. Alcami, A., and G.L. Smith. 1992. A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell. 71:153-167.